The Study on the Efficacy and Safety of Lactobacillus Johnsonii in Combination with CapeOX and Pembrolizumab for the Treatment of MSS/pMMR Metastatic Colorectal Cancer.
Clinical trial NCT06823323 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06823323
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.